Accretion Nutravedaa IPO: Modernizing Ayurvedic & Pharma Contract Manufacturing IPO

Introduction

Accretion Nutravedaa Limited is a fast-growing contract manufacturing organization (CMO) specializing in Ayurvedic formulations and pharmaceutical intermediaries. By combining ancient Wisdom with modern manufacturing technology, the company provides high-quality, standardized wellness products to major national and international brands. Their upcoming SME IPO is aimed at upgrading their production facilities to meet international regulatory standards.

IPO Snapshot

• Price Band: ₹122 – ₹129 per share
• Issue Size: ₹24.77 Cr
• Type: SME IPO
• Lot Size: 1000 shares
• Face Value: ₹10 per share
• Dates: Jan 28 – Jan 30, 2026

Company Deep Dive

Accretion Nutravedaa operates a state-of-the-art manufacturing unit capable of producing tablets, capsules, syrups, and ointments under strict GMP guidelines. Their R&D team works closely with clients to develop innovative nutraceautical and Ayurvedic products that cater to the evolving health consciousness of consumers. The company’s commitment to quality and transparency in sourcing raw materials has made them a trusted partner in the pharma and wellness industry.

Financial Performance

The company has maintained a healthy financial profile with low debt and steady revenue growth. For the most recent fiscal period, Accretion Nutravedaa reported total revenue of ₹16 Cr. Its Profit After Tax (PAT) was recorded at ₹2.61 Cr, reflecting strong net margins characteristic of the high-value contract manufacturing segment.

Objectives of the Issue

The gross proceeds from the Fresh Issue are intended to be used for:

1. Upgrading existing manufacturing lines to WHO-GMP standards.
2. Establishing a specialized testing laboratory for herb-drug interaction studies.
3. Repayment of a portion of outstanding term loans.
4. General corporate purposes.

Risk Factors

• Regulatory Compliance: Any failure to maintain manufacturing standards or pass regulatory inspections can lead to facility shutdowns.
• Contractual Risks: As a CMO, the company is dependent on renewal of contracts with its key clients.
• Intellectual Property: Protecting proprietary formulations and process innovations is critical and challenging.